furosemide has been researched along with Breast Neoplasms in 15 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1." | 9.07 | Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992) |
| "Breast cancer is one of the leading causes of death in women worldwide." | 5.91 | Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer. ( Al-Shehri, M; Kaushik, AC; Mehmood, A; Wang, L; Wang, Z; Wei, DQ; Yao, J; Zhang, H, 2023) |
| "Frusemide 20mg/Spironolactone 50 mg), every other day for 4 weeks." | 5.27 | The Role of Diuretics in Treatment of Aromatase Inhibitors Induced Musculoskeletal Symptoms in Women with Non Metastatic Breast Cancer ( Alhanafy, AM; Khalil, A; Labeeb, A, 2018) |
| "To determine the effect of prednisolone on severe hypercalcaemia in women with metastatic breast cancer, 30 patients with serum ionized calcium above 1." | 5.07 | Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study. ( Ejlertsen, B; Holmegaard, SN; Krarup-Hansen, A; Kristensen, B; Mouridsen, H; Transbøl, I, 1992) |
| "Among the 48 human ABC proteins, the breast cancer resistance protein (BCRP/ABCG2) has been described as a pivotal player in cancer resistance." | 2.82 | Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. ( Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF, 2022) |
| "Breast cancer is one of the leading causes of death in women worldwide." | 1.91 | Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer. ( Al-Shehri, M; Kaushik, AC; Mehmood, A; Wang, L; Wang, Z; Wei, DQ; Yao, J; Zhang, H, 2023) |
| "Risk of breast cancer in women was assessed for eight pharmaceuticals that produce mammary tumors in experimental animals, using nested case-control analyses in two cohorts with prescription records in a comprehensive medical care program." | 1.35 | Pharmaceuticals that cause mammary gland tumors in animals: findings in women. ( Chan, J; Friedman, GD; Habel, LA; Jiang, SF; Quesenberry, CP; Udaltsova, N, 2009) |
| "Primary hyperparathyroidism is caused by an adenoma/hyperplasia in the parathyroid glands in which hypercalcemia is mainly due to an increased secretion of parathormone (PTH)." | 1.35 | [Primary hyperparathyroidism. An alternative to the surgery]. ( Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zattoni, IF | 1 |
| Delabio, LC | 1 |
| Dutra, JP | 1 |
| Kita, DH | 1 |
| Scheiffer, G | 1 |
| Hembecker, M | 1 |
| Pereira, GDS | 1 |
| Moure, VR | 1 |
| Valdameri, G | 1 |
| Wang, Z | 1 |
| Mehmood, A | 1 |
| Yao, J | 1 |
| Zhang, H | 1 |
| Wang, L | 1 |
| Al-Shehri, M | 1 |
| Kaushik, AC | 1 |
| Wei, DQ | 1 |
| Alhanafy, AM | 1 |
| Labeeb, A | 1 |
| Khalil, A | 1 |
| Friedman, GD | 1 |
| Jiang, SF | 1 |
| Udaltsova, N | 1 |
| Chan, J | 1 |
| Quesenberry, CP | 1 |
| Habel, LA | 1 |
| Díaz Guardiola, P | 1 |
| Vega Piñero, B | 1 |
| Alameda Hernando, C | 1 |
| Pavón de Paz, I | 1 |
| Iglesias Bolaños, P | 1 |
| Guijarro de Armas, G | 1 |
| Xepapadakis, G | 1 |
| Ntasiou, P | 1 |
| Koronarchis, D | 1 |
| Koufoudakis, D | 1 |
| Panousis, D | 1 |
| Grosomanidis, D | 1 |
| Venizelos, V | 1 |
| Georgiadis, S | 1 |
| Becher, R | 1 |
| Löhren, D | 1 |
| Firusian, N | 1 |
| Guo, JH | 1 |
| Song, ST | 1 |
| Xu, ZL | 1 |
| Kristensen, B | 1 |
| Ejlertsen, B | 1 |
| Holmegaard, SN | 1 |
| Krarup-Hansen, A | 1 |
| Transbøl, I | 1 |
| Mouridsen, H | 1 |
| Pérez, C | 1 |
| Alvarez, M | 1 |
| Pérez, I | 1 |
| Arriagada, D | 1 |
| Schwarz, F | 1 |
| Manku, MS | 1 |
| Nassar, BA | 1 |
| Horrobin, DF | 1 |
| Humbert, G | 2 |
| Fillastre, JP | 2 |
| Leroy, J | 2 |
| Robert, M | 1 |
| Delaunay, P | 1 |
| Deshayes, P | 1 |
| Baum, M | 1 |
2 reviews available for furosemide and Breast Neoplasms
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Dr | 2022 |
[Acute hypercalcemia as an oncological emergency. Pathogenesis, clinical aspects, therapy].
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Electrocardiography; Female; Fluid Therapy; | 1980 |
2 trials available for furosemide and Breast Neoplasms
| Article | Year |
|---|---|
The Role of Diuretics in Treatment of Aromatase Inhibitors Induced Musculoskeletal Symptoms in Women with Non Metastatic Breast Cancer
Topics: Aged; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Diuretics; Egypt; Female; Furosemide; Huma | 2018 |
Prednisolone in the treatment of severe malignant hypercalcaemia in metastatic breast cancer: a randomized study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Calcium; Female; Fluid Therapy; Furosemide; Hum | 1992 |
11 other studies available for furosemide and Breast Neoplasms
| Article | Year |
|---|---|
Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer.
Topics: Breast Neoplasms; Dopamine; Female; Furosemide; Gold; Humans; Transcriptome | 2023 |
Pharmaceuticals that cause mammary gland tumors in animals: findings in women.
Topics: Adult; Aged; Antifungal Agents; Antiprotozoal Agents; Breast Neoplasms; Case-Control Studies; Diuret | 2009 |
[Primary hyperparathyroidism. An alternative to the surgery].
Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbid | 2009 |
New views on treatment of aromatase inhibitors induced arthralgia.
Topics: Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Diuretics; Female; Furosemide; Humans | 2010 |
[The protective effects of two hydration protocols against cisplatin nephrotoxicity].
Topics: Adult; Breast Neoplasms; Cisplatin; Female; Furosemide; Humans; Kidney; Kidney Diseases; Male; Middl | 1994 |
[Severe hypercalcemia: response to treatment].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Calcium; Female; Furosemide; Human | 1988 |
[Palliative treatment of the edematous arm in breast cancer].
Topics: Arm; Breast Neoplasms; Female; Furosemide; Humans; Lymphedema; Palliative Care | 1972 |
Frusemide as inhibitor of prolactin action.
Topics: Animals; Breast Neoplasms; Drug Interactions; Female; Furosemide; Kidney Diseases; Lactation; Male; | 1973 |
[Acute hypercalcemia. Treatment with Furosemide].
Topics: Adenoma; Adult; Aged; Blood Urea Nitrogen; Blood Volume; Breast Neoplasms; Calcitonin; Calcium; Crea | 1972 |
[The treatment of acute hypercalcemias with furosemide].
Topics: Adenoma; Adult; Aged; Breast Neoplasms; Female; Furosemide; Humans; Hypercalcemia; Lymphoma, Non-Hod | 1973 |
Why Does the Weeping Willow Weep? Reconceptualizing Oncogenesis in Breast Cancer.
Topics: Breast Neoplasms; Carcinogenesis; Esthetics; Female; Fractals; Humans; Lactation; Mammary Glands, Hu | 2015 |